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Due to a unique pattern of CD8 T-cell response induced by cyto-
megaloviruses (CMVs), live attenuated CMVs are attractive candi-
dates for vaccine vectors for a number of clinically relevant
infections and tumors. NKG2D is one of the most important acti-
vating NK cell receptors that plays a role in costimulation of CD8 T
cells. Here we demonstrate that the expression of CD8 T-cell epi-
tope of Listeria monocytogenes by a recombinant mouse CMV
(MCMV) expressing the NKG2D ligand retinoic acid early-inducible
protein 1-gamma (RAE-1γ) dramatically enhanced the effective-
ness and longevity of epitope-speciﬁc CD8 T-cell response and
conferred protection against a subsequent challenge infection
with Listeria monocytogenes. Unexpectedly, the attenuated growth
in vivo of the CMV vector expressing RAE-1γ and its capacity to
enhance speciﬁc CD8 T-cell response were preserved even in mice
lacking NKG2D, implying additional immune function for RAE-1γ
beyond engagement of NKG2D. Thus, vectors expressing RAE-1γ
represent a promising approach in the development of CD8 T-cell–
based vaccines.
RAE-1 gamma | CD8 T cell vaccine | vaccine vector
Although vaccination plays a tremendous role in protectionagainst infectious diseases, there are many pathogens for
which even the immunity acquired after natural infection does
not fully protect against reinfection and disease. Therefore,
vaccines which offer superior protection compared with the
protection following natural infection are needed. Most of the
current vaccines induce protective antibodies but often fail to
confer sufﬁcient protection. An alternative approach is to de-
velop vaccines which are based on the induction of cellular im-
munity in general and cytotoxic CD8 T cells in particular (1).
Cytomegaloviruses (CMVs) are excellent inducers of the CD8
T-cell response, despite having numerous immunoevasion strat-
egies aimed at compromising antigen presentation by MHC class
I molecules (2). Preferentially, CMVs induce the effector arm of
memory CD8 T cells (3). This, together with a large genome
allowing the insertion of multiple foreign genes, makes CMVs
attractive vaccine vectors. The outstanding capacity of speciﬁc
CD8 T cells induced by CMV vectors was proven by studies
demonstrating the role of tissue-resident effector memory CD8
T cells in the protection against challenge infection (4, 5). The
suitability of CMV as a vaccine vector was further emphasized in
a recent study by Hansen et al. (6).
NKG2D is a receptor expressed on several lymphocyte subsets,
with a predominant role in activation of NK cells. In addition,
NKG2D has a costimulatory role on CD8 T cells (7). The ligands
for the NKG2D receptor are several molecules induced by stress
or cell transformation. In mice, NKG2D ligands comprise the
RAE-1 family (RAE-1α–e), H60 family (H60a–c), and MULT-1
proteins (8). The signiﬁcance of NKG2D signaling in immune
response to CMV infection is best illustrated by numerous
strategies used by CMVs to evade the function of this receptor (9).
We have recently shown that infection of mice with mouse CMV
(MCMV) expressing RAE-1γ elicits a strong and long-lasting
MCMV-speciﬁc CD8 T-cell response, despite a dramatic virus
attenuation as a consequence of efﬁcient NK cell control (10).
Here we demonstrate that MCMV expressing RAE-1γ has
a tremendous potential for boosting the efﬁciency of CD8 T cells
directed against a vectored antigenic peptide. We show that
CMV expressing RAE-1γ and immunodominant CD8 T-cell epi-
tope of Listeria monocytogenes listeriolysin O (LLO) or ovalbumin-
derived SIINFEKL induces a superior epitope-speciﬁc and durable
protective CD8 T-cell response. Moreover, our study indicates the
existence of another, so far unknown, immune function of RAE-1γ
beyond engagement of NKG2D. Altogether, our data set the stage
for a powerful, unique approach in designing T-cell–based vaccines.
Results
CMV Expressing RAE-1γ and Listeriolysin Epitope Induces a Strong
Listeriolysin-Speciﬁc CD8 T-Cell Response. To test the potential of
using MCMV expressing RAE-1γ as a vector, we have con-
structed a virus expressing immunodominant CD8 T-cell epitope
of L. monocytogenes listeriolysin O91–99 (LLO) (11) on the back-
bone of RAE-1γMCMV (10), where RAE-1γ was introduced in
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place of its viral inhibitor m152 (RAE-1γMCMVList). The LLO
epitope was introduced in place of the MCMV immunodominant
CD8 T-cell epitope m164167–175 (Fig. 1A). MCMV expressing the
LLO epitope only (MCMVList) was used as control. Neither of
the genetic modiﬁcations affected viral growth kinetics in vitro
(Fig. S1 A and B). As shown by the viral load in spleen and lungs
of infected mice, RAE-1γMCMVList, but not MCMVList, was
severely attenuated in BALB/c (H-2d) mice (Fig. 1B). Despite the
striking attenuation, RAE-1γMCMVList induced a stronger LLO-
speciﬁc CD8 T-cell response compared with MCMVList (Fig. 1C
and Fig. S1C). To exclude the possibility that the robustness of the
CD8 T-cell response after infection with RAE-1γMCMVList
vector was restricted to a single MHC I haplotype, C57BL/6
(H-2b) mice were infected with RAE-1γMCMV expressing the
H-2Kb–restricted peptide SIINFEKL (RAE-1γMCMV-SIINFEKL)
(12) (Fig. 1A). The infection with RAE-1γMCMV-SIINFEKL
resulted in a higher frequency of SIINFEKL-speciﬁc CD8 T cells
compared with the infection with MCMV expressing SIINFEKL
only (Fig. 1D). The CD8 T-cell response to some, but not all,
MCMV immunodominant epitopes was also superior in RAE-
1γMCMV-SIINFEKL–infected mice (Fig. S1D). Altogether, the
results demonstrated the capacity of MCMV expressing RAE-1γ
to potentiate the CD8 T-cell response directed against vectored
CD8 T-cell epitopes.
Superior Protection Against a Challenge Infection in Mice Immunized
with RAE-1γMCMV Expressing Antigenic Peptides. LLO-speciﬁc CD8
T cells play a major role in the protection against L. monocytogenes
in BALB/c mice (11, 13). To prove the efﬁciency of RAE-
1γMCMVList as a vaccine, BALB/c mice were immunized with
RAE-1γMCMVList, MCMVList, or WT MCMV and tested for
protective capacity against a challenge infection with L. mono-
cytogenes 3 wk later (Fig. 2A). Mice were killed 4 d postchallenge
and analyzed for bacterial load in the spleen and liver (Fig. 2B).
Naive mice and mice immunized with WT MCMV showed higher
bacterial loads in both organs, and a signiﬁcant proportion of them
succumbed to the infection. The vaccination with MCMVList
resulted in a modest reduction of the bacterial load in the spleen
but not in the liver compared with WTMCMV. In contrast, RAE-
1γMCMVList induced efﬁcient protection that was demonstrated
by a dramatic reduction of the bacterial load in both organs. An
important consequence of L. monocytogenes infection is the de-
pletion of T cells in the periarteriolar lymphoid sheath of infected
spleens (14) (Fig. 2C). Whereas mice infected with MCMVList
showed only a low level of protection, periarteriolar T cells were
completely preserved upon immunization with RAE-1γMCMVList.
The superior property of RAE-1γMCMV as a vaccine vector was
further illustrated by the higher frequency of LLO-speciﬁc CD8
T cells and their capacity for IFN-γ and TNF-α production after
challenge infection with L. monocytogenes (Fig. 2D).
To test the efﬁciency of RAE-1γ expressing MCMV vectors
in a second model, C57BL/6 mice were primed with viruses ex-
pressing SIINFEKL either with or without RAE-1γ coexpression
and challenged with L. monocytogenes expressing ovalbumin
(OVA-Listeria) (Fig. 2E). The results demonstrated superior
resistance of RAE-1γMCMV-SIINFEKL–immunized mice to
challenge with OVA-Listeria.
CD8 T Cells Represent a Dominant Protective Mechanism Against
Challenge Infection in RAE-1γMCMVList–Vaccinated Mice. To dem-
onstrate that CD8 T cells are responsible for the durable protective
effect of RAE-1γMCMVList vaccination, a group of immunized
BALB/c mice was depleted of CD8 T cells before the challenge
infection. The depletion of CD8 T cells abolished the protection of
RAE-1γMCMVList immunization against L. monocytogenes chal-
lenge (Fig. 3A). This was also conﬁrmed by histopathological
analysis of the livers of immunized mice (Fig. S2). Although RAE-
1γMCMVList immunization signiﬁcantly prevented the formation
of lesions, the CD8 T-cell depletion resulted in a pathology that was
similar to the one observed in other groups of mice. The immuni-
zation with MCMVList was insufﬁcient to limit liver pathology
caused by infection, indicating that CD8 T cells expressed as a result
of immunization with RAE-1γ expresing vector were dominant in
the protection against L. monocytogenes challenge.
Longevity of Memory CD8 T-Cell Response Induced by RAE-1γMCMVList.
To assess whether the vaccination with MCMV vector expressing
RAE-1γ provides a long-lasting protection against L. mono-
cytogenes, we have challenged the mice by infecting them 2 mo
postvaccination. Groups of vaccinated BALB/c mice challenged
with 2 × 104 cfu per mouse of L. monocytogenes were monitored for
survival and body weight loss (Fig. 3B). All unvaccinated mice and
most of the mice infected with WTMCMV succumbed to infection
by day 4, which was accompanied by a dramatic weight loss by day 3
postchallenge. Vaccination with MCMVList protected a substantial
fraction of the immunized mice, but nevertheless, these mice ex-
hibited a signiﬁcant weight loss. All RAE-1γMCMVList–vaccinated
mice survived the infection with minimal weight loss by day 4
postchallenge. Mice which survived 4 d postinfection were killed,
and the bacterial loads in spleen were determined (Fig. 3C). When
mice were challenged with higher inoculums (4 × 104 cfu per
mouse), it was demonstrated that RAE-1γMCMVList–vaccinated
mice could still resist the challenge (Fig. 3D). The efﬁcient and
long-lasting protective capacity of the LLO-speciﬁc CD8 T-cell re-
sponse in mice vaccinated with RAE-1γMCMVList was conﬁrmed
by assessing the LLO-speciﬁc CD8 T-cell–mediated cytotoxicity in
Fig. 1. Expression of RAE-1γ by an MCMV vector improves the speciﬁc CD8
T-cell response to a vectored antigen. (A) RAE-1γMCMVList and RAE-
1γMCMV-SIINFEKL were constructed on the RAE-1γMCMV backbone by
replacing the Dd-restricted antigenic m164 peptide 167AGPPRYSRI175 with
either the Kd-restricted listeriolysin O (LLO)-derived peptide 91GYKDGNEYI99
or the H-2Kb–restricted ovalbumin-derived peptide SIINFEKL. (B) BALB/c mice
were infected i.v. with 2 × 105 pfu per mouse of the indicated viruses, and
viral titers were determined by plaque assay. DL, detection limit. (C) Sple-
nocytes of MCMVList- or RAE-1γMCMVList–infected BALB/c mice (105 pfu per
mouse, via f.p.) were stained for LLO tetramer-speciﬁc CD8 T cells. (D) C57BL/
6 mice were f.p. infected with 105 pfu per mouse of MCMV-SIINFEKL or RAE-
1γMCMV-SIINFEKL. At indicated time points, splenocytes were isolated,
stimulated with SIINFEKL-peptide, and stained for the intracellular IFN-γ
production. For panels B–D, individual animals (circles or triangles) and
median values are shown.









vivo (Fig. 3E). Listeriolysin-speciﬁc killing was signiﬁcantly higher
for at least 11 mo postvaccination in mice vaccinated with RAE-
1γMCMVList. Altogether, it can be concluded that the herpesviral
vector engineered to express the NKG2D ligand RAE-1γ provided
highly efﬁcient long-term CD8 T-cell–mediated protection against
L. monocytogenes infection.
Better Priming of CD8 T Cells and Attenuation of RAE-1γMCMVList Are
Consequences of Ectopic Expression of RAE-1γ.Although it has been
previously shown that the deletion of MCMV inhibitors of MHC
class I presentation does not enhance the CD8 T-cell response
(3), this possibility could not be completely excluded, particularly
because m152 is also a viral inhibitor of RAE-1 expression (9). To
investigate whether RAE-1γ alone or accompanied by deletion of
m152 enhances the potency of our viral vector, a virus expressing
the LLO epitope on the backbone of the m152-deﬁcient virus (15)
(Δm152MCMVList) was used. Δm152MCMVList showed at-
tenuated growth in vivo, but the level of attenuation was much
more pronounced with the RAE-1γMCMVList (Fig. S3A).
Furthermore, the frequency of LLO-speciﬁc CD8 T cells induced
by Δm152MCMVList at day 8 postinfection was inferior com-
pared with the level induced by the RAE-1γMCMVList (Fig.
S3B). However, at later time points we have observed a high
frequency of epitope-speciﬁc CD8 T cells also in mice infected
with Δm152MCMVList, suggesting an impact of m152 deletion.
These data led us to conclude that the major mechanism behind
attenuation and improved CD8 T-cell response in mice infected
with virus expressing RAE-1γ does not result from endogenous
RAE-1γ or improved MHC-I presentation due to deletion of
m152 but rather from the ectopic expression of RAE-1γ.
NKG2D-Independent Immune Function of RAE-1γ. Next, we wanted
to investigate how RAE-1γ, in the context of MCMV vector,
mediates its immune-stimulatory effects. It has been well estab-
lished that costimulation via NKG2D plays an important role in
shaping of the CD8 T-cell response (7, 16). This function may be
crucial for efﬁcient priming of CD8 T cells by RAE-1γMCMV
because MCMV down-regulates costimulatory molecules on
antigen-presenting cells as does HCMV (17, 18). Therefore, we
investigated the capacity of RAE-1γMCMVList to prime CD8 T
cells in the presence of blocking NKG2D antibodies. Blocking of
NKG2D signiﬁcantly reduced but did not completely abolish the
control of RAE-1γMCMVList at day 3 postinfection (p.i.) (Fig.
4A). Surprisingly, we observed that CD8 T-cell responses were not
diminished in the presence of blocking antibodies in either
BALB/c or C57BL/6 mice (Fig. 4 B and C). These observations
suggested an NKG2D-independent role for RAE-1γ. To ensure
that our observations were not the result of insufﬁcient blocking
of RAE-1γ–NKG2D interactions, we took advantage of mice
Fig. 2. RAE-1γMCMV expressing antigenic peptides protects mice against
L. monocytogenes. (A) Mice were immunized via f.p. with 105 pfu per mouse
of WT MCMV or MCMV vector with or without RAE-1γ or were left non-
immunized. At 3 wk p.i. or later, mice were challenged with L. mono-
cytogenes. On day 4 postchallenge, mice were sacriﬁed and analyzed for an
immune response and protective capacity to L. monocytogenes. (B) BALB/c
mice were challenged 4 wk postimmunization with 2 × 104 cfu per mouse of
L. monocytogenes. Bacterial load was determined in spleen and liver. In-
dividual animals (circles) and median values are shown. † indicates the death
of a mouse. (C) Three weeks postimmunization, BALB/c mice were challenged
with 104 cfu per mouse of L. monocytogenes. Parafﬁn-embedded spleen sec-
tions were stained for CD3e expression. * indicates central artery. PALS, peri-
arteriolar lymphoid sheath. (Magniﬁcation: 20×.) (D) Splenocytes were isolated
and either stained with LLO-tetramers or stimulated with LLO-peptides and
intracellularly stained for cytokine production (mean ± SEM, n = 4–5). (E) Three
weeks postvaccination, C57BL/6 mice were challenged with 5 × 104 cfu per
mouse of OVA-Listeria. Individual animals and median values are shown.
Fig. 3. Long-term protection against L. monocytogenes challenge in RAE-
1γMCMVList–immunized mice. BALB/c mice were f.p. immunized with 105
pfu per mouse of indicated viruses. (A) Three weeks postimmunization, mice
were challenged with 104 cfu per mouse of L. monocytogenes. One day
before the challenge, mice were depleted of CD8 T cells or left undepleted.
Four days later, the bacterial loads were determined (mean ± SEM, n = 4–5).
(B) Challenge with 2 × 104 cfu per mouse of L. monocytogenes was per-
formed 60 d postimmunization. Survival and body weight loss (mean ± SEM)
on day 3 (n = 9–12) is shown. (C) Bacterial load of survived mice on day 4
postchallenge in spleen is shown (individual animals and median values,
n = 9; † indicates the death of a mouse). (D) Challenge with 4 × 104 cfu per
mouse of L. monocytogenes was performed 60 d postimmunization, and
the survival rate was followed (n = 9). (E ) Mice were injected with an equal
ratio of unstimulated and LLO-peptide–stimulated CSFE-stained spleno-
cytes 2 and 11 mo postimmunization. Percentage of listeriolysin peptide-
speciﬁc killing is shown (mean ± SEM, n = 3–4).
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lacking the NKG2D receptor (NKG2D−/− mice) (19). C57BL/6
mice and NKG2D−/− mice were i.v. infected with either WT
MCMV, MCMV-SIINFEKL, or RAE-1γMCMV-SIINFEKL,
and the virus titers in organs were determined at day 7 p.i. (Fig.
4D). MCMV expressing RAE-1γ was attenuated not only in
control C57BL/6 mice but also in NKG2D−/− mice. Moreover, in
accordance with our ﬁndings after the application of blocking
antibodies, we also found a higher frequency of SIINFEKL-
speciﬁc CD8 T cells in NKG2D−/− mice after infection with
RAE-1γMCMV-SIINFEKL compared with MCMV-SIINFEKL
(Fig. 4E). This difference did not depend on the absence of
m152 because RAE-1γMCMV-SIINFEKL was much more
attenuated than Δm152MCMV-SIINFEKL in both WT and
NKG2D−/− mice (Fig. 4F). These ﬁndings suggested that RAE-
1γ has an immune-stimulatory role beyond the engagement
of NKG2D.
Next, we tested whether NKG2D-independent triggering of CD8
T cells in RAE-1γMCMV-SIINFEKL infection of NKG2D−/−
mice inﬂuenced their protective capacity as well. C57BL/6 and
NKG2D−/− mice were immunized with either WT MCMV,
MCMV-SIINFEKL, or RAE-1γMCMV-SIINFEKL, and 3 wk
later, mice were challenged with 5 × 104 cfu per mouse of OVA-
Listeria (Fig. 5). NKG2D−/−mice immunized with RAE-1γMCMV-
SIINFEKL were equally as protected against infection as C57BL/6
mice, once again demonstrating the capacity of RAE-1γ expressed
in context of MCMV vector to induce robust protective immune
response even in mice lacking NKG2D signaling.
MCMV Expressing RAE-1γ Preserves Dendritic Cell Subsets and Enables
Priming of CD8 T Cells. Dendritic cells (DCs) are known targets of
MCMV, and infection with WT MCMV results in a dramatic re-
duction of splenic DCs in the early days p.i (20, 21). However, in
comparison with WT MCMV, the virus expressing RAE-1γ affects
the frequency of DCs in the spleen to a much smaller extent (10)
(Fig. 6A). Although the deletion of m152 on its own prevented the
loss of DCs in spleen compared with WTMCMV, both DC subsets
were preserved to a much higher level in mice infected with
RAE-1γMCMVList. The preserved frequency of DCs in RAE-
1γMCMVList–infected mice was not a consequence of NK cell
disfunction because we showed that their functional capacity was
completely preserved (Fig. S4). The preservation of DCs during
early days p.i. corresponded to the enhanced priming of CD8 T
cells in RAE-1γMCMVList–infected mice, which was illustrated by
the higher frequencies of LLO-speciﬁc CD8 T cells (Fig. 1C and
Fig. S1C) and a higher proliferation capacity of CD8 T cells (Fig.
6B). This was in inverse correlation with the level of IFN-α in the
sera of RAE-1γMCMVList–infected mice (Fig. 6C). Thus, we can
conclude that the expression of RAE-1γ by MCMV promotes the
priming of CD8 T cells by preserving antigen-presenting cells.
Although it is generally assumed that cross-presentation plays
a dominant role in the priming of CD8 T cells during MCMV
infection (3, 22, 23), we proposed that priming in mice infected
with MCMV expressing RAE-1γ would not be dependent on
cross-presentation because a lowered antigenic load should, at
least in theory, reduce the cross-priming capacity of such a virus.
To test this hypothesis, we used 3d mice defective in TLR3,
TLR7, and TLR9 signaling which are unable to cross-present
foreign antigens (24). The 3d mice were infected with either
MCMV-SIINFEKL or RAE-1γMCMV-SIINFEKL, and the fre-
quency of SIINFEKL-speciﬁc and MCMV-speciﬁc (M45) CD8
T cells was determined 7 d later (Fig. 6D). Although both viruses
induced an epitope-speciﬁc CD8 T-cell response, the one in-
duced by RAE-1γMCMV-SIINFEKL was slightly stronger than
the one in mice infected with MCMV-SIINFEKL. Additionally,
the priming capacity of RAE-1γMCMV vector was assessed in
Batf3−/− mice deﬁcient for CD8α+ DCs, which can present an-
tigenic peptides through direct or cross-presentation mechanisms
(25, 26). In contrast to control C57BL/6 mice and 3d mice,
the priming capacity of both RAE-1γMCMV-SIINFEKL and
MCMV-SIINFEKL was dramatically reduced in Batf3−/− mice,
suggesting the crucial role of this speciﬁc DC subset rather
than cross-presentation as such (Fig. 6E). However, contrary
to the mice infected with MCMV-SIINFEKL, the CD8 T-cell
response to RAE-1γMCMV-SIINFEKL was not completely
abolished in Batf3−/− mice, suggesting independent priming of
some CD8α+ DCs.
Fig. 4. NKG2D-independent attenuation and immune function of RAE-1γ.
(A) BALB/c mice were infected i.v. with 2 × 105 pfu per mouse of the in-
dicated viruses. One day before infection and on days 2 and 5 p.i., mice were
treated with αNKG2D antibody. Virus titer was determined on day 8 p.i. (B)
Mice were infected with 105 pfu per mouse via f.p. and treated with αNKG2D
as in A. LLO-speciﬁc CD8 T-cell response was determined on day 8 p.i. (n = 5).
(C) C57BL/6 mice were infected with 2 × 105 pfu per mouse i.v. and treated
with αNKG2D. The frequency of SIINFEKL-speciﬁc CD8 T cells was determined
on day 8 p.i. (n = 3–4). (D) C57BL/6 and NKG2D−/−mice were infected i.v. with
2 × 105 pfu per mouse. On day 7 p.i., virus titer is shown. (E) The frequency of
SIINFEKL-speciﬁc CD8 T cells was determined on day 7 p.i. (n = 3–4). (F) Virus
titer in organs was determined on day 7 p.i. For A, D, and F, individual
animals and median values are shown. For B, C, and E, mean ± SEM is shown.
Fig. 5. RAE-1γMCMV expressing SIINFEKL-peptide protects mice against
OVA-Listeria in NKG2D−/− mice. C57BL/6 and NKG2D−/− mice were immu-
nized with 105 pfu per mouse via f.p. of indicated viruses or left non-
immunized. Three weeks postimmunization, mice were challenged with 5 ×
104 cfu per mouse of OVA-Listeria. The bacterial load was determined. In-
dividual animals (circles) and median values are shown.









To investigate more directly the effect of RAE-1γ on memory
CD8 T-cell differentiation, naive CD8 T cells from MHC class
I-restricted TCR transgenic mice (27) with a high speciﬁcity for
the MCMV-derived epitope M38 were i.v. injected into C57BL/6
mice. One day later, recipient C57BL/6 mice were i.v. injected with
either WT MCMV, Δm152MCMV, or RAE-1γMCMV. On days
7 and 14 p.i., CD8 T cells from spleens (Fig. S5) were analyzed
for the frequency of short-lived effector cells (KLRG1+CD127−)
and memory precursor effector cells (MPECs) (KLRG1−CD127+)
(28). A signiﬁcant shift in favor of MPECs was observed in mice
infected with RAE-1γMCMV virus.
To investigate whether this effect of RAE-1γ on the pattern of
memory CD8 T-cell differentiation is NKG2D-dependent,
NKG2DΔ/Δ mice, a second NKG2D-deﬁcient mouse line gen-
erated in our laboratory (29), were crossed on OT-1 TCR
transgenic C57BL/6 mice (30). NKG2DΔ/ΔOT-1 cells were
transferred into syngeneic naive C57BL/6 recipients infected
with either MCMV-SIINFEKL, Δm152MCMV-SIINFEKL, or
RAE-1γMCMV-SIINFEKL (Fig. 6F). The frequency of MPEC
NKG2DΔ/ΔOT-1 CD8 T cells within donor CD8 T cells in blood
on days 7 and 14 p.i. was tested. Similarly to the results obtained
with M38 TCR transgenic mice, the frequency of MPECs within
donor cells was the highest in mice infected with RAE-1γMCMV-
SIINFEKL. To rule out the possibility that ectopically expressed
RAE-1γ (recognized by host’s cells expressing NKG2D) was
inﬂuencing the transition of transferred NKG2DΔ/ΔOT-1 toward
MPECs, we have transferred NKG2DΔ/ΔOT-1 cells and
NKG2D+/−OT-1 into NKG2D-deﬁcient recipients and analyzed
their expansion and MPEC formation on day 7 p.i. As shown in
Fig. S6, the frequency of SIINFEKL-speciﬁc MPECs transferred
from either NKG2DΔ/ΔOT-1 or control OT-1 mice was higher in
mice infected with RAE-1γMCMV vector. Altogether, the results
indicate that the ectopic expression of RAE-1γ in the MCMV
vector accelerates the transition of the CD8 T-cell response toward
memory cell differentiation in a NKG2D-independent manner.
Discussion
A better understanding of subset diversiﬁcation of antigen-spe-
ciﬁc CD8 T cells during immune responses is key for designing
T-cell–based vaccines. The strength and the quality of the CD8
T-cell response is determined by various factors including anti-
genic stimulation through the TCR, various costimulation sig-
nals, and stimulation via inﬂammatory cytokines (31, 32). These
signals shape the CD8 T cells’ differentiation toward short-living
effector cells and long-living memory T cells (28, 33, 34). Here
we demonstrate that an MCMV vector expressing RAE-1γ, de-
spite its dramatically attenuated growth in vivo, boosts the
quality of the speciﬁc CD8 T-cell response against vectored an-
tigenic epitopes. Moreover, the CD8 T-cell response to LLO and
SIINFEKL epitopes induced by MCMV vector expressing RAE-
1γ demonstrated a superior and long-lasting protection against
a challenge infection with L. monocytogenes and L. mono-
cytogenes expressing OVA. In addition, the phenotype of MCMV
expressing RAE-1γ, with regard to its attenuation and the quality
of protective CD8 T-cell response to vectored antigens, was
also preserved in NKG2D−/− mice, demonstrating the NKG2D-
independent immune function of RAE-1γ.
MCMV efﬁciently down-regulates costimmulatory molecules
in infected cells which may result in deﬁcient priming of CD8 T
cells (17). Because NKG2D can also serve as a costimulatory
receptor, we designed our RAE-1γMCMV vector to circumvent
viral evasins of costimmulatory signaling. Our goal was to at-
tenuate in vivo replication of our vector, while simultaneously
enhancing its capacity to prime CD8 T cells. The molecular
communication between DCs and CD8 T cells regulates both the
magnitude and the quality of the resulting CD8 T-cell response.
Thus, improved antigen presentation with MCMV expressing
RAE-1γ can, at least in part, be explained by a preserved fre-
quency of DCs and by rescuing their costimmulatory capacity
through RAE-1γ. It is worth emphasizing that preserved CD8α+
DC subset rather than cross-presentation mechanism is the
dominant factor for CD8 T-cell priming in mice infected with the
RAE-1γMCMV vector. This is in line with more recent ﬁndings
demonstrating that MCMV-speciﬁc CD8 T-cell priming is de-
pendent on the CD8α+ DC subset rather than on cross-pre-
sentation (25).
The promoting effect of NKG2D ligands on speciﬁc CD8
T-cell responses is not without precedent in the literature: it has
been shown that NKG2D ligands RAE-1 and H60 ectopically
expressed on tumor cell lines strongly enhance the generation of
tumor-speciﬁc CD8 T-cell response and are able to protect an
immunized host against a challenge with the original tumor lines
lacking the NKG2D ligands (35). Here we demonstrated that
MCMV expressing RAE-1γ has improved priming potential also
in NKG2D−/− mice, suggesting an NKG2D-independent func-
tion of RAE-1γ. Further studies are needed to deﬁne the mo-
lecular basis of this NKG2D-independent function of RAE-1γ. It
is also possible that this NKG2D-independent immune function
is expressed or even induced only in NKG2D-deﬁcient mice.
However, the inability of NKG2D blocking to abolish the effect
of RAE-1γ on CD8 T-cell priming argues in favor of a constitu-
tive existance of NKG2D-independent function for RAE-1γ.
Priming in the absence of a systemic inﬂammation accelerates
the transition of early-memory to late-memory CD8 T cells (36).
In contrast, immunization accompanied with a strong induction
of proinﬂamatory cytokines prevents the transition of memory
CD8 T cells, while only minimally altering their expansion. Our
Fig. 6. RAE-1γ expression promotes epitope-speciﬁc CD8 T cells priming.
BALB/c mice were i.v. infected with 2 × 105 pfu, and the following param-
eters were analyzed: (A) the frequency of DC subsets in spleen, (B) the fre-
quency of proliferating CD8 T cells, and (C) IFN-α level in the sera. For A–C,
mean ± SEM is shown; n = 3–5. (D) C57BL/6 and 3d mice were i.p. infected
with 2 × 105 pfu of indicated viruses and the speciﬁc CD8 T-cell response in
spleen was determined on day 7 p.i. (E) C57BL/6 and Batf3−/− mice were
infected i.v. with 2 × 105 pfu of indicated viruses and SIINFEKL-speciﬁc CD8 T
cells in spleen were determined on day 8 p.i. Mean ± SEM is shown. (F) Naive
recipients (CD45.1) were transferred with 104 NKG2DΔ/ΔOT1 cells (CD45.2)
and infected with 104 pfu per mouse of indicated viruses 24 h later. On days
7 and 14 p.i., donor CD8 T cells (CD45.1) were analyzed for the frequency of
MPECs (KLRG1−CD127+ CD8 T cells) in blood (n = 3). Representative FACS
plots of donor MPECs expansion are shown; n = 3–4.
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results with RAE-1γMCMV vector are in line with this scenario
because the level of type I IFN was much lower in RAE-
1γMCMV vector-immunized mice compared with the mice
infected with WT MCMV. Together with the observation that
CD8 T cells in RAE-1γMCMV vector-primed mice secrete
higher levels of IFNγ and TNFα, these ﬁndings indicate a quali-
tative difference of memory response after immunization with
MCMV vector expressing RAE-1γ.
Stimulation of CD8 T cells has been widely recognized as
a method of choice for the development of new vaccines against
various pathogens and tumors. RAE-1γMCMV is unique among
CD8 T-cell experimental vaccine vectors for several reasons: (i)
it is strongly attenuated in vivo; (ii) it possesses deletion of viral
immunoevasin, whose product negatively regulates not only the
expression of RAE-1γ but also MHC-I presentation; and (iii)
it promotes a CD8 T-cell response superior to the response
obtained by a vector lacking RAE-1γ expression. Moreover, it
generates and maintaines lifelong protective immunity without
the need for prime-boost immunization protocols. Bearing in
mind that ULBP2 is a homolog of RAE-1γ (37), the translation
of these results into a HCMV vector system may be critical for
the design of HCMV-based vaccine vectors for various infections
and tumors.
Materials and Methods
Mice. BALB/c, C57BL/6, NKG2D−/− (19), OT-1 and Klrk1Δ/ΔOT1 (NKG2DΔ/ΔOT1)
(29), M38 TCR transgenic (27), and C57BL/6 Ly5.1 mice were bred under
speciﬁc pathogen free conditions at the Faculty of Medicine, University of
Rijeka. The 3d mice (24) were bred and maintained at the Helmholtz Centre
for Infection Research. Batf3−/−mice were kindly provided by Thomas Brocker
(Ludwig Maximilian University, Munich, Germany). All experimental proce-
dures were approved by the Ethics Committee of the University of Rijeka.
Infection. Mice were infected with MCMV strains at the age of 6–12 wk by
injection of the virus in 50 μL of the diluent when administered via footpad
(f.p.) or 500 μL of the diluent when administered i.v. The hemolytic EGD
strain (serovar1/2a) of L.monocytogenes and recombinant L. monocytogenes
that stably express the chicken ovalbumin (aa134–387) (38) were cultured to
an exponential growth phase. Infection was performed in 500 μL of pyro-
gen-free saline i.v.
Flow Cytometry and Immune Assays. For CD8 T-cell in vitro cytokine production,
splenocytes were stimulated with 1 μg of MHC class I restricted peptides,
followed by incubation in the presence of Brefeldin A (eBioscience).
Statistics. Statistical signiﬁcance was determined by GraphPad Prism5 Soft-
ware. The differences in viral titers and bacterial load were determined by
a two-tailed Mann-Whitney u test. The differences in CD8 T-cell frequencies
were determined by a two-tailed Mann-Whitney u test or two-tailed un-
paired Student t test. The signiﬁcant differences between tested groups are
indicated with star symbols as follows: *P < 0.05, **P < 0.01, ***P < 0.001,
and ****P < 0.0001. Differences between groups were determined with
one-way ANOVA analysis assuming not-repeated measures, followed by
Bonferroni posttest. P values of <0.05 were considered signiﬁcant.
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